Autek China Inc
SZSE:300595

Watchlist Manager
Autek China Inc Logo
Autek China Inc
SZSE:300595
Watchlist
Price: 16.71 CNY -2.39%
Market Cap: 15B CNY
Have any thoughts about
Autek China Inc?
Write Note

Autek China Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Autek China Inc
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Autek China Inc
SZSE:300595
Short-Term Investments
ÂĄ2.1B
CAGR 3-Years
126%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Short-Term Investments
ÂĄ338.9m
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Short-Term Investments
ÂĄ20.1m
CAGR 3-Years
-65%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Short-Term Investments
ÂĄ3.3B
CAGR 3-Years
474%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Short-Term Investments
ÂĄ3.1B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Short-Term Investments
ÂĄ2.4B
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Autek China Inc
Glance View

Market Cap
15B CNY
Industry
Health Care

Autek China Inc. stands as an emblematic figure in the dynamic landscape of medical devices and biotechnology in China. Rooted in its mission to innovate within the realms of diagnostic imaging and therapeutic ultrasound equipment, the company has maneuvered through this niche market by leveraging both cutting-edge technology and strategic partnerships. Autek's portfolio includes a range of high-quality ultrasound machines and imaging solutions that cater to the rapidly evolving needs of hospitals and clinics. By capitalizing on the growing demand for advanced healthcare services in China, Autek has tailored its product offerings to resonate with local market needs while maintaining competitive pricing strategies. This keen understanding of market dynamics allows Autek to maintain a robust sales pipeline and forge sturdy relationships within the medical community, driving its revenue growth engine. The company's operational blueprint hinges on an impressive blend of research-driven innovation and effective distribution networks. Autek continually invests in research and development, aspiring to push technological boundaries and uphold its reputation as a pioneer in the medical imaging sector. This investment lays the groundwork for creating state-of-the-art products that are not only technologically advanced but also user-friendly for medical professionals. Autek's adeptness at navigating regulatory landscapes ensures smooth market entry and expansion for its offerings. Furthermore, its strategic alliances with healthcare providers and government entities enhance its distribution network, ensuring that its products reach a wide spectrum of healthcare institutions across China. Autek makes its money by selling its technologically advanced and reliable devices, as well as providing ongoing support and maintenance services, forming the backbone of its revenue model and securing its position in the competitive arena.

Intrinsic Value
22.09 CNY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Autek China Inc's Short-Term Investments?
Short-Term Investments
2.1B CNY

Based on the financial report for Sep 30, 2024, Autek China Inc's Short-Term Investments amounts to 2.1B CNY.

What is Autek China Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
25%

Over the last year, the Short-Term Investments growth was 124%. The average annual Short-Term Investments growth rates for Autek China Inc have been 126% over the past three years , 25% over the past five years .

Back to Top